Amitriptyline vs Nortriptyline
Both amitriptyline and nortriptyline are tricyclic antidepressants. Nortriptyline, a major metabolite of amitriptyline, is a secondary amine. It is less sedating and better tolerated than amitriptyline. But both have similar side effects, toxicities, and pharmacologic activity.
Amitriptyline and nortriptyline are FDA-approved. Amitriptyline has been better studied and its various off-label uses are better established.
Amitriptyline inhibits serotonin and noradrenaline uptake equally, whereas nortriptyline is a more potent inhibitor of noradrenaline than of serotonin uptake. Nortriptyline has a longer half-life.
Nortriptyline is unique among the antidepressants in that its blood level exhibits the classical therapeutic window effect. Blood concentrations above or below the therapeutic window (60-200 ng/ml) correlate with poor clinical response. Thus, therapeutic monitoring to ensure the drug level within the therapeutic window is critical for successful treatment with nortriptyline.
Nortriptyline provides more rapid antidepressant effect.
Amitriptyline vs Desipramine
Desipramine appears to produce the greater reduction in pain intensity. Clinically meaningful pain relief (moderate or better) is significantly more likely with desipramine than with amitriptyline.